Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastrointestinal Neoplasms × Nucleotides × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Gastrointestinal Neoplasms 1

Interventions

Oxaliplatin 24 Fluorouracil 22 Leucovorin 19 Surveys and Questionnaires 15 Irinotecan 15 Capecitabine 13 Bevacizumab 12 Drug Therapy 10 Cisplatin 10 Gemcitabine 9 Nivolumab 8 Blood Specimen Collection 8 Standard of Care 7 S 1 (combination) 6 Cetuximab 6 atezolizumab 5 Sunitinib 5 Endoscopic Mucosal Resection 5 Educational Status 5 Cyclophosphamide 5 pembrolizumab 4 Radiotherapy 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Interviews as Topic 4 Folfox protocol 4 Everolimus 4 Docetaxel 4 130-nm albumin-bound paclitaxel 4 tegafur-gimeracil-oteracil 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01423799 2015-11-13

Neoimmune

Société des Produits Nestlé (SPN)

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡